{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T18:37:41Z","timestamp":1791916661092,"version":"4.3.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,2,17]],"date-time":"2009-02-17T00:00:00Z","timestamp":1234828800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1186\/1471-2334-9-18","type":"journal-article","created":{"date-parts":[[2009,2,17]],"date-time":"2009-02-17T14:14:46Z","timestamp":1234880086000},"source":"Crossref","is-referenced-by-count":76,"title":["Using high titer West Nile intravenous immunoglobulin from selected Israeli donors for treatment of West Nile virus infection"],"prefix":"10.1186","volume":"9","author":[{"given":"David","family":"Ben-Nathan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orly","family":"Gershoni-Yahalom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itzchak","family":"Samina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yevgeny","family":"Khinich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israel","family":"Nur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orgad","family":"Laub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahuva","family":"Gottreich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Simanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Porgador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bracha","family":"Rager-Zisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadav","family":"Orr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,2,17]]},"reference":[{"key":"783_CR1","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1128\/CMR.13.4.602-614.2000","volume":"13","author":"MA Keller","year":"2000","unstructured":"Keller MA, Stiehm ER: Passive immunity in prevention and treatment of infectious diseases. Clin Microbiol Rev. 2000, 13: 602-614. 10.1128\/CMR.13.4.602-614.2000.","journal-title":"Clin Microbiol Rev"},{"key":"783_CR2","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/nrmicro974","volume":"2","author":"A Casadevall","year":"2004","unstructured":"Casadevall A, Dadachova E, Pirofski LA: Passive antibody therapy for infectious diseases. Nat Rev Microbiol. 2004, 2: 695-703. 10.1038\/nrmicro974.","journal-title":"Nat Rev Microbiol"},{"key":"783_CR3","doi-asserted-by":"crossref","first-page":"471","DOI":"10.4269\/ajtmh.1940.s1-20.471","volume":"20","author":"KC Smithburn","year":"1940","unstructured":"Smithburn KC, Hughes TP, Burke AW, Paul JH: A neutrotropic virus isolated from the blood of a native of Uganda. Am J Trop Med. 1940, 20: 471-492.","journal-title":"Am J Trop Med"},{"key":"783_CR4","volume-title":"Fields Virology","author":"SD Burke","year":"2001","unstructured":"Burke SD, Monath TP: Flaviviruses. Fields Virology. Edited by: Field BN, Knipe DM, Howley PM. 2001, Philadelphia: Lippincott-Raven"},{"key":"783_CR5","doi-asserted-by":"publisher","first-page":"697","DOI":"10.3201\/eid0704.017418","volume":"7","author":"JH Scherret","year":"2001","unstructured":"Scherret JH, Poidinger M, Mackenzie JS, Broom AK, Deubel V, Lipkin WI, Briese T, Gould EA, Hall RA: The relationships between West Nile and Kunjin viruses. Emerg Infect Dis. 2001, 7: 697-705.","journal-title":"Emerg Infect Dis"},{"key":"783_CR6","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1056\/NEJM200106143442401","volume":"344","author":"D Nash","year":"2001","unstructured":"Nash D, Mostashari F, Fine A, Miller J, O'Leary D, Murray K, Huang A, Rosenberg A, Greenberg A, Sherman M, et al: The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med. 2001, 344: 1807-1814. 10.1056\/NEJM200106143442401.","journal-title":"N Engl J Med"},{"key":"783_CR7","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1086\/506939","volume":"43","author":"PJ Carson","year":"2006","unstructured":"Carson PJ, Konewko P, Wold KS, Mariani P, Goli S, Bergloff P, Crosby RD: Long-term clinical and neuropsychological outcomes of West Nile virus infection. Clin Infect Dis. 2006, 43: 723-730. 10.1086\/506939.","journal-title":"Clin Infect Dis"},{"key":"783_CR8","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/ncpneuro0176","volume":"2","author":"RL Debiasi","year":"2006","unstructured":"Debiasi RL, Tyler KL: West Nile virus meningoencephalitis. Nat Clin Pract Neurol. 2006, 2: 264-275. 10.1038\/ncpneuro0176.","journal-title":"Nat Clin Pract Neurol"},{"key":"783_CR9","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1146\/annurev.med.57.121304.131418","volume":"57","author":"EB Hayes","year":"2006","unstructured":"Hayes EB, Gubler DJ: West Nile virus: epidemiology and clinical features of an emerging epidemic in the United States. Annu Rev Med. 2006, 57: 181-194. 10.1146\/annurev.med.57.121304.131418.","journal-title":"Annu Rev Med"},{"key":"783_CR10","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.3201\/eid1108.050289a","volume":"11","author":"EB Hayes","year":"2005","unstructured":"Hayes EB, Komar N, Nasci RS, Montgomery SP, O'Leary DR, Campbell GL: Epidemiology and transmission dynamics of West Nile virus disease. Emerg Infect Dis. 2005, 11: 1167-1173.","journal-title":"Emerg Infect Dis"},{"key":"783_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1084\/jem.20051970","volume":"203","author":"WG Glass","year":"2006","unstructured":"Glass WG, McDermott DH, Lim JK, Lekhong S, Yu SF, Frank WA, Pape J, Cheshier RC, Murphy PM: CCR5 deficiency increases risk of symptomatic West Nile virus infection. J Exp Med. 2006, 203: 35-40. 10.1084\/jem.20051970.","journal-title":"J Exp Med"},{"key":"783_CR12","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1086\/497340","volume":"192","author":"I Yakub","year":"2005","unstructured":"Yakub I, Lillibridge KM, Moran A, Gonzalez OY, Belmont J, Gibbs RA, Tweardy DJ: Single nucleotide polymorphisms in genes for 2'-5'-oligoadenylate synthetase and RNase L inpatients hospitalized with West Nile virus infection. J Infect Dis. 2005, 192: 1741-1748. 10.1086\/497340.","journal-title":"J Infect Dis"},{"key":"783_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/376871","volume":"188","author":"AG Agrawal","year":"2003","unstructured":"Agrawal AG, Petersen LR: Human immunoglobulin as a treatment for West Nile virus infection. J Infect Dis. 2003, 188: 1-4. 10.1086\/376871.","journal-title":"J Infect Dis"},{"key":"783_CR14","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1586\/14787210.3.6.931","volume":"3","author":"MS Diamond","year":"2005","unstructured":"Diamond MS: Development of effective therapies against West Nile virus infection. Expert Rev Anti Infect Ther. 2005, 3: 931-944. 10.1586\/14787210.3.6.931.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"783_CR15","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1086\/508293","volume":"194","author":"JD Morrey","year":"2006","unstructured":"Morrey JD, Siddharthan V, Olsen AL, Roper GY, Wang H, Baldwin TJ, Koenig S, Johnson S, Nordstrom JL, Diamond MS: Humanized monoclonal antibody against West Nile virus envelope protein administered after neuronal infection protects against lethal encephalitis in hamsters. J Infect Dis. 2006, 194: 1300-1308. 10.1086\/508293.","journal-title":"J Infect Dis"},{"key":"783_CR16","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1034\/j.1399-3062.2002.01014.x","volume":"4","author":"A Hamdan","year":"2002","unstructured":"Hamdan A, Green P, Mendelson E, Kramer MR, Pitlik S, Weinberger M: Possible benefit of intravenous immunoglobulin therapy in a lung transplant recipient with West Nile virus encephalitis. Transpl Infect Dis. 2002, 4: 160-162. 10.1034\/j.1399-3062.2002.01014.x.","journal-title":"Transpl Infect Dis"},{"key":"783_CR17","doi-asserted-by":"publisher","first-page":"759","DOI":"10.3201\/eid0704.017432","volume":"7","author":"Z Shimoni","year":"2001","unstructured":"Shimoni Z, Niven MJ, Pitlick S, Bulvik S: Treatment of West Nile virus encephalitis with intravenous immunoglobulin. Emerg Infect Dis. 2001, 7: 759-","journal-title":"Emerg Infect Dis"},{"key":"783_CR18","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1086\/376870","volume":"188","author":"D Ben-Nathan","year":"2003","unstructured":"Ben-Nathan D, Lustig S, Tam G, Robinzon S, Segal S, Rager-Zisman B: Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice. J Infect Dis. 2003, 188: 5-12. 10.1086\/376870.","journal-title":"J Infect Dis"},{"key":"783_CR19","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1086\/519392","volume":"196","author":"CB Planitzer","year":"2007","unstructured":"Planitzer CB, Modrof J, Kreil TR: West Nile virus neutralization by US plasma-derived immunoglobulin products. J Infect Dis. 2007, 196: 435-440. 10.1086\/519392.","journal-title":"J Infect Dis"},{"key":"783_CR20","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1354\/vp.37-3-208","volume":"37","author":"KE Steele","year":"2000","unstructured":"Steele KE, Linn MJ, Schoepp RJ, Komar N, Geisbert TW, Manduca RM, Calle PP, Raphael BL, Clippinger TL, Larsen T, et al: Pathology of fatal West Nile virus infections in native and exotic birds during the 1999 outbreak in New York City, New York. Vet Pathol. 2000, 37: 208-224. 10.1354\/vp.37-3-208.","journal-title":"Vet Pathol"},{"key":"783_CR21","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1007\/BF01718826","volume":"141","author":"D Ben-Nathan","year":"1996","unstructured":"Ben-Nathan D, Lustig S, Kobiler D: Cold stress-induced neuroinvasiveness of attenuated arboviruses is not solely mediated by corticosterone. Arch Virol. 1996, 141: 1221-1229. 10.1007\/BF01718826.","journal-title":"Arch Virol"},{"key":"783_CR22","first-page":"493","volume":"27","author":"LJ Reed","year":"1938","unstructured":"Reed LJ, Muench H: A simple method of estimating fifty percent end points. Am J Hyg. 1938, 27: 493-497.","journal-title":"Am J Hyg"},{"key":"783_CR23","volume-title":"Whole cells antigen preparations","author":"BWJ Mahy","year":"1996","unstructured":"Mahy BWJ, Kangro HO: Whole cells antigen preparations. 1996, London: Academic Press, Harcourt Brace & Company"},{"key":"783_CR24","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1128\/JCM.38.5.1823-1826.2000","volume":"38","author":"DA Martin","year":"2000","unstructured":"Martin DA, Muth DA, Brown T, Johnson AJ, Karabatsos N, Roehrig JT: Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections. J Clin Microbiol. 2000, 38: 1823-1826.","journal-title":"J Clin Microbiol"},{"key":"783_CR25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0022-1759(98)00170-7","volume":"221","author":"A Frey","year":"1998","unstructured":"Frey A, Di Canzio J, Zurakowski D: A statistically defined endpoint titer determination method for immunoassays. J Immunol Methods. 1998, 221: 35-41. 10.1016\/S0022-1759(98)00170-7.","journal-title":"J Immunol Methods"},{"key":"783_CR26","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1677\/joe.0.1790139","volume":"179","author":"PN Moynagh","year":"2003","unstructured":"Moynagh PN: Toll-like receptor signalling pathways as key targets for mediating the anti-inflammatory and immunosuppressive effects of glucocorticoids. J Endocrinol. 2003, 179: 139-144. 10.1677\/joe.0.1790139.","journal-title":"J Endocrinol"},{"key":"783_CR27","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3201\/eid0808.010516","volume":"8","author":"A Casadevall","year":"2002","unstructured":"Casadevall A: Passive antibody administration (immediate immunity) as a specific defense against biological weapons. Emerg Infect Dis. 2002, 8: 833-841.","journal-title":"Emerg Infect Dis"},{"key":"783_CR28","doi-asserted-by":"publisher","first-page":"12941","DOI":"10.1128\/JVI.77.24.12941-12949.2003","volume":"77","author":"MJ Engle","year":"2003","unstructured":"Engle MJ, Diamond MS: Antibody prophylaxis and therapy against West Nile virus infection in wild-type and immunodeficient mice. J Virol. 2003, 77: 12941-12949. 10.1128\/JVI.77.24.12941-12949.2003.","journal-title":"J Virol"},{"key":"783_CR29","doi-asserted-by":"publisher","first-page":"e88","DOI":"10.1086\/377172","volume":"37","author":"M Haley","year":"2003","unstructured":"Haley M, Retter AS, Fowler D, Gea-Banacloche J, O'Grady NP: The role for intravenous immunoglobulin in the treatment of West Nile virus encephalitis. Clin Infect Dis. 2003, 37: e88-90. 10.1086\/377172.","journal-title":"Clin Infect Dis"},{"key":"783_CR30","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/j.1749-6632.2001.tb02704.x","volume":"951","author":"JT Roehrig","year":"2001","unstructured":"Roehrig JT, Staudinger LA, Hunt AR, Mathews JH, Blair CD: Antibody prophylaxis and therapy for flavivirus encephalitis infections. Ann N Y Acad Sci. 2001, 951: 286-297.","journal-title":"Ann N Y Acad Sci"},{"key":"783_CR31","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nm1240","volume":"11","author":"T Oliphant","year":"2005","unstructured":"Oliphant T, Engle M, Nybakken GE, Doane C, Johnson S, Huang L, Gorlatov S, Mehlhop E, Marri A, Chung KM, et al: Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus. Nat Med. 2005, 11: 522-530. 10.1038\/nm1240.","journal-title":"Nat Med"},{"key":"783_CR32","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/BF01309481","volume":"137","author":"M Halevy","year":"1994","unstructured":"Halevy M, Akov Y, Ben-Nathan D, Kobiler D, Lachmi B, Lustig S: Loss of active neuroinvasiveness in attenuated strains of West Nile virus: pathogenicity in immunocompetent and SCID mice. Arch Virol. 1994, 137: 355-370. 10.1007\/BF01309481.","journal-title":"Arch Virol"},{"key":"783_CR33","doi-asserted-by":"publisher","first-page":"14606","DOI":"10.1128\/JVI.79.23.14606-14613.2005","volume":"79","author":"LH Gould","year":"2005","unstructured":"Gould LH, Sui J, Foellmer H, Oliphant T, Wang T, Ledizet M, Murakami A, Noonan K, Lambeth C, Kar K, et al: Protective and therapeutic capacity of human single-chain Fv-Fc fusion proteins against West Nile virus. J Virol. 2005, 79: 14606-14613. 10.1128\/JVI.79.23.14606-14613.2005.","journal-title":"J Virol"},{"key":"783_CR34","doi-asserted-by":"crossref","first-page":"356","DOI":"10.4269\/ajtmh.2006.75.356","volume":"75","author":"R Mateo","year":"2006","unstructured":"Mateo R, Xiao SY, Guzman H, Lei H, Da Rosa AP, Tesh RB: Effects of immunosuppression on West Nile virus infection in hamsters. Am J Trop Med Hyg. 2006, 75: 356-362.","journal-title":"Am J Trop Med Hyg"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-9-18\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-9-18.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-9-18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-9-18.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T17:52:08Z","timestamp":1589565128000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-9-18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,17]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["783"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-9-18","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,17]]},"article-number":"18"}}